Inventor · disambiguated record
Jeffrey D. Kent
Also filed as: KENT JEFFREY · KENT JEFFREY D
4 granted patents·12 pending applications·11 citations·filing 2007–2024
65Inventor score
Files withHORIZON THERAPEUTICS USA INC5KUPPER HARTMUT4BOTSON JOHN2HORIZON PHARMA RHEUMATOLOGY LLC2MEDICH JOHN R2
Top patents by PatentIndex Score
16 records- 0180US9399061B2Methods for determining efficacy of TNF-α inhibitors for treatment of rheumatoid arthritisKUPPER HARTMUT·Filed 2007·Granted Jul 26, 2016·11 cites·6 claims
- 0269US2024033331A1Reducing immunogenicity to pegloticaseHORIZON THERAPEUTICS USA INC·Filed 2023·Application pending·0 cites
- 0367US2025009849A1Tolerization reduces intolerance to pegloticase and prolongs the urate lowering effect (triple)HORIZON THERAPEUTICS USA INC·Filed 2024·Application pending·0 cites
- 0466US12465631B2Reducing immunogenicity to pegloticaseHORIZON THERAPEUTICS USA INC·Filed 2022·Granted Nov 11, 2025·0 cites·18 claims
- 0558US2020353057A1Reducing immunogenicity to pegloticaseHORIZON PHARMA RHEUMATOLOGY LLC·Filed 2020·Application pending·0 cites
- 0656US12121566B2Methods for treating goutHORIZON THERAPEUTICS USA INC·Filed 2020·Granted Oct 22, 2024·0 cites·16 claims
- 0754US2015064195A1Uses and compositions for treatment of rheumatoid arthritisKUPPER HARTMUT·Filed 2014·Application pending·0 cites
- 0854US2015056212A1Uses and Compositions for Treatment of Rheumatoid ArthritisKUPPER HARTMUT·Filed 2014·Application pending·0 cites
- 0954US2020237880A1Reducing immunogenicity to pegloticaseHORIZON PHARMA RHEUMATOLOGY LLC·Filed 2020·Application pending·0 cites
- 1054US2015064194A1Uses and Compositions for Treatment of Rheumatoid ArthritisKUPPER HARTMUT·Filed 2014·Application pending·0 cites
- 1151US2017157249A1Uses and compositions for treatment of rheumatoid arthritisABBVIE BIOTECHNOLOGY LTD·Filed 2016·Application pending·0 cites
- 1249US2008131374A1Uses and compositions for treatment of rheumatoid arthritisMEDICH JOHN R·Filed 2007·Application pending·0 cites
- 1346US2020237881A1Reducing immunogenicity to pegloticaseBOTSON JOHN·Filed 2020·Application pending·0 cites
- 1445US2022409620A1Reducing immunogenicity to pegloticaseBOTSON JOHN·Filed 2021·Application pending·0 cites
- 1542US2012171123A1Uses and compositions for treatment of rheumatoid arthritisMEDICH JOHN R·Filed 2011·Application pending·0 cites
- 1639US12496331B2Combination therapies of prednisone and uricase molecules and uses thereofHORIZON THERAPEUTICS USA INC·Filed 2017·Granted Dec 16, 2025·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Jeffrey D. Kent files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →